Trial Profile
A prospective, randomized, double blind study of onabotulinumtoxinA, abobotulinumtoxinA, and incobotulinumtoxinA in dynamic glabellar rhytide reduction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Feb 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Glabellar lines
- Focus Therapeutic Use
- 13 Feb 2017 New trial record